TScan Therapeutics, Inc. (TCRX) received a neutral rating from Wedbush, as analyst David Nierengarten reassessed the stock in light of recent market conditions. With a current price of $0.3811 and a price target of $5.00, this rating reflects cautious investor sentiment as the company navigates challenging terrain. Recent Price Action TCRX has experienced notable fluctuations

On September 3, 2026, Sonoco Products Company (SON) received a “Neutral” rating from George Staphos of B of A Securities, representing a pivotal point for investors assessing the company’s outlook. Despite a promising price target of $69 compared to its current trading price of $54.74, the neutral stance suggests analysts are cautious about near-term upside

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) received an “In-Line” rating from Liisa Bayko of Evercore ISI Group on September 3, 2026, a pivotal moment for investors watching its volatile stock. This rating comes against a backdrop of significant price declines, suggesting potential stabilization ahead, with an average price target of $50.56, indicating potential upside from the

On September 3, 2026, PG&E Corporation (NYSE: PCG) received a “Hold” rating from Richard Sunderland of Truist Securities, who posits an upside potential for the stock with a target price of $21 against the current trading price of $13.33. This rating change signals a cautious stance, suggesting that while the company has potential for growth,

Moderna, Inc. (MRNA) has been assigned a ‘Sell’ rating by Rothschild & Co’s Simon Baker, raising concerns over the company’s upcoming performance. The new price target of $81 suggests significant downside from its current trading level of $150.81. This rating change marks a critical moment for investors, warranting a close examination of Moderna’s stock movements,

In a notable move, Covista Inc. (CVSA) has received a “Hold” rating from Jasper Bibb of Truist Securities on September 3, 2026. This rating reflects a cautious but stable outlook for the company, aligning with its current stock price of $134.16 and a price target set at $140. Investors may find this adjustment to be

In a notable shift for investors, NIO Inc. (NIO) received a “Neutral” rating from JP Morgan analyst Nick Lai on September 2, 2026. This assessment signals a cautious stance amid fluctuating market conditions, while the price target remains unchanged at $7. This development invites investors to reconsider their positions in this leading electric vehicle manufacturer,

On September 2, 2026, Martin Marietta Materials, Inc. (NYSE: MLM) received an upgrade to “Overweight” from Adrian Heurta of JP Morgan, positioning the stock for significant upside potential based on a new price target of $680. This rating change signals a bullish outlook for the company, compelling investors to reassess their positions in light of

In a notable shift in sentiment towards Knife River Corporation (NYSE: KNF), JP Morgan analyst Adrian Huerta downgraded the stock to “Underweight” on September 2, 2026. This rating change reflects concerns about the company’s short-term performance, suggesting that investors may need to tread carefully in the current market environment. With a current share price of

On September 2, 2026, JPMorgan analyst Adrian Huerta assigned a Neutral rating to Amrize Ltd (AMRZ), reflecting a steady outlook amidst a challenging earnings report. The rating signifies a cautious stance from investors navigating a stock that currently trades at $42.97, although Huerta’s price target of $57 suggests notable upside potential. For investors, this could

Sirius XM Holdings Inc. (SIRI) was upgraded to a Buy rating by Bryan Kraft of Deutsche Bank on September 2, 2026, reflecting optimism surrounding the company’s future performance. With a current share price of $27.62 and a price target set at $45, this new rating suggests substantial upside potential for investors, making it a stock

OGE Energy Corp. (OGE) recently received an “Outperform” rating from RBC Capital’s Stephen D’Ambrisi on September 2, 2026, suggesting a bullish outlook for the utility company. The newly assigned price target of $54 presents a substantial upside from the stock’s recent trading price of $45.99, which signals an appealing opportunity for investors looking for growth